Spots Global Cancer Trial Database for autologous t cells
Every month we try and update this database with for autologous t cells cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy | NCT00001440 | Breast Neoplasm Neoplasm Metast... | Autologous T ce... Interleukin-2 | - | National Institutes of Health Clinical Center (CC) | |
| Autologous Redirected RNA Meso-CIR T Cells | NCT01355965 | Malignant Pleur... | Autologous T ce... | 18 Years - | University of Pennsylvania | |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma | NCT04995003 | Sarcoma HER-2 Protein O... Osteosarcoma Rhabdomyosarcom... Ewing Sarcoma Synovial Sarcom... Soft Tissue Sar... Undifferentiate... | T cells or CAR ... Pembrolizumab I... Nivolumab Injec... | 1 Year - 25 Years | Baylor College of Medicine | |
| Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC) | NCT01140373 | Prostate Cancer | engineered auto... cyclophosphamid... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab | NCT01416974 | Leukemia | cyclophosphamid... modified T cell... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab | NCT01416974 | Leukemia | cyclophosphamid... modified T cell... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma | NCT04995003 | Sarcoma HER-2 Protein O... Osteosarcoma Rhabdomyosarcom... Ewing Sarcoma Synovial Sarcom... Soft Tissue Sar... Undifferentiate... | T cells or CAR ... Pembrolizumab I... Nivolumab Injec... | 1 Year - 25 Years | Baylor College of Medicine | |
| Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy | NCT00001440 | Breast Neoplasm Neoplasm Metast... | Autologous T ce... Interleukin-2 | - | National Institutes of Health Clinical Center (CC) | |
| Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated Glioma | NCT05478837 | Diffuse Midline... | Cyclophosphamid... Fludarabine Autologous Anti... | 3 Years - 25 Years | University of California, San Francisco |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
